NOVARTIS AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 97.97 USD | -1.52% |
|
-0.04% | -2.03% |
| 05-31 | NOVARTIS AG : UBS reiterates its Buy rating | ZD |
| 05-31 | European Equities Close Higher in Friday Trading; Flash Euro Area Inflation Rises More Than Expected | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 734B | ||||||
| 591B | ||||||
| 350B | ||||||
| 315B | ||||||
| 276B |
